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Background—The objective of this study was to examine the association of routine blood test re-
sults with coronary heart disease (CHD) risk, to incorporate them into coronary prediction models 
and to compare the discrimination properties of this approach with other prediction functions. 
Methods  and  Results—This  work  was  designed  as  a  retrospective,  single-center  study  of  a 
hospital-based cohort. The 5060 CHD patients (2365 men and 2695 women) were 1 to 97 years old 
at baseline with 8 years (2009–2017) of medical records, 5051 health check-ups and 5075 cases of 
other diseases. We developed a two-layer Gradient Boosting Decision Tree(GBDT) model based on 
routine blood data to predict the risk of coronary heart disease, which could identify 86% of people 
with coronary heart disease. We built a dataset with 15,000 routine blood tests results. Using this 
dataset, we trained the two-layer GBDT model to classify healthy status, coronary heart disease and 
other diseases. As a result of the classification after machine learning, we found that the sensitivity 
of detecting the health data was approximately 93% for all data, and the sensitivity of detecting 
CHD was 93% for disease data that  included coronary heart  disease.  On this basis,  we further 
visualized the correlation between routine blood results and related data items, and there was an 
obvious pattern in health and coronary heart disease in all data presentations, which can be used for 
clinical  reference.  Finally,  we  briefly  analyzed  the  results  above  from  the  perspective  of 
pathophysiology. 
Conclusions—Routine blood data provides more information about CHD than what we already 
know through the correlation between test results and related data items. A simple coronary disease 
prediction model was developed using a GBDT algorithm, which will allow physicians to predict 
CHD risk in patients without overt CHD. 
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I. INTRODUCTION
Early and accurate identification of individuals 
with  increased risk  of  coronary heart  disease 
(CHD) is critical for effective implementation 
of  preventative  lifestyle  modifications  and 
medical  interventions,  such  as  statin 
treatment[1,2].  Thus,  risk  scores  such  as  the 
Framingham Risk Score (FRS)[3], the Ameri-
can College of Cardiology/American Heart As-
sociation  2013  risk  score  (ACC/AHA13)[1] 
and  genomic  risk  score  (GRS)  for  CHD[4], 
which are based on clinical factors, lipid mea-
surements and genome-wide association stud-
ies  (GWAS),  have  been  developed  for  CHD 
risk prediction. Although the scores can identi-
fy individuals at very high risk, a large propor-
tion of individuals developing CHD during the 
next 10 years are not identified by these risk 
scores because they may be young, the tests are 
not  affordable  or  they do not  have access  to 
sufficient  healthcare to be evaluated by these 
risk scores.
It is very important to make full use of data in 
conventional medical service to identify high-
risk populations with CHD using low-cost au-
tomation. This study shows that there is a sig-
nificant  correlation  between  CHD  and  blood 
components,  and  since  routine  blood  routine 
examination is performed in most patients dur-
ing  routine  medical  service,  it  is  simple  and 
effective to evaluate the risk of CHD by using 
routine blood test data. 
II. MATERIALS AND METHODS
A total  of 16860 patients were enrolled from 
eastern China; 5060 patients had CHD, includ-
ing 5051 undergoing routine health check-ups 
and 5075 cases of other diseases.
The technical  route  consisted of  clinical  data 
collection, clinical data preprocessing, and fea-
ture  engineering,  and  the  data  were  merged 
into a health set, a diseased set, a CHD set and 
another disease set according to the diagnosis. 
Then,  the  machine  learning  algorithm model 
training, model evaluation, feature importance 
and correlation analysis were carried out.
Clinical data collection: According to the tar-
get  population,  from the relevant  information 
system,  we  collected  medical  information  of 
patients  with  CHD,  including  patients  before 
admission  from  their  outpatient  examination 
data, the treatment period of collection of the 
examination data and other examination data. 
In addition, the health examination data of the 
healthy population and other patients' examina-
tion data were collected. These data included 
the  patients’  basic  information,  laboratory 
check data, diagnostic data, etc.
Clinical  data  preprocessing:  Since  the  col-
lected medical data usually have the character-
istics  of  high  volume,  large  sparsity  and  di-
verse data types, it is necessary to preprocess 
the data.
The preprocessing steps were as follows.
1)Data types were converted to the same type 
for  different  types  of  data,  including  the 
conversion of "male" in the gender data to 1 
and the conversion of "female" to 0.
2)For data markers, the original data were di-
vided  into  three  categories:  CHD  patient 
data, other disease patient data and healthy 
population data, respectively labeled "1", “−
1", and "0". 
3)Data that are missing values are deleted to 
improve  the  effectiveness  of  data,  because 
the  collection  of  medical  data  sparsity  is 
high. Then, the missing values are filled with 
the  average value,  specifically,  the  missing 
value of coronary heart disease is filled with 
the average of coronary heart disease, as are 
other diseases and health data.
4)Anomaly deletion was performed when the 
data  in  the process  of  production or  trans-
mission  would  produce  an  abnormal  situa-
tion, combined with the business scene and 
specific rules to identify and remove the ex-
ception point. 
5)Data  integration  was  performed  after  the 
above  steps;  the  remaining  data  totaled 
15,033.  To  ensure  the  balance  of  training 
data, the data from 5,000 patients were ran-
domly sampled from the CHD patient data, 
other disease patient data and healthy popu-
lation data,  and the data were consolidated 
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by  the  1:1:1  ratio  to  generate  a  complete 
dataset.
Feature Engineering: Statistics of the missing 
degree of each feature were performed before 
the data missing value was filled, because the 
healthy population underwent a health exami-
nation, causing the healthy population to have 
the highest data integrity. The main feature is 
the blood routine 22 examination index, which 
other data mostly lacks and therefore uses the 
basic information and the blood routine exami-
nation index to construct the feature set, which 
includes  gender,  age,  WBC,  RBC,  MCHC, 
MONO, HCT,  NEUT,  MCV, PLT,  HGB,  LY, 
LY%,  MONO%,  NEUT%,  RDW,  BASO%, 
HgB,  EOS,  BASO,  EOS%,  MPV,  PCT,  and 
PDW.
Selection and training of models: according 
to the features of the dataset after preprocess-
ing, we chose three different machine learning 
algorithms,  LR  (Logistic  Regression),  SVM 
(Support Vector Machines) and GBDT (Gradi-
ent  Boosting  Decision  Tree).  LR  is  a  very 
common  algorithm  in  the  field  of  machine 
learning, which is widely used and is a classi-
cal classification model. SVM was proposed in 
1995 by Corinna Cortes and Vapnik and other 
people looking for a hyperplane to classify the 
data, with relatively good performance indica-
tors[9].  GBDT  was  presented  in  2001  by 
Friedman[5,6]  and  is  composed  of  Decision 
Tree Learning[7] and Gradient Boosting[8].
Our experiment is divided into two layers, the 
first layer is a health and disease two classifica-
tion model,  the second layer is for CHD and 
other diseases two classification model, using 
Mathieu  Blondel’s  and  other  people’s  devel-
oped  Sklearn  library[14]  for  model  training. 
The steps were as follows.
1)Dataset  markup was  performed in  the  first 
layer. The healthy population data were la-
beled “-1" and disease patient  data labeled 
"1" (including patients with CHD and other 
diseases).
2)Dataset  partitioning  was  performed  in  the 
first layer. Of the 15,000 marked data, 5,000 
healthy people and randomly selected 5,000 
patients were merged into a dataset, then we 
randomly  sampled  70%  of  the  data  as  a 
training set used for the training model, and 
the  remaining  30% as  a  validation  set  for 
model effect evaluation.
3)Dataset  markup was also performed in  the 
second  layer.  Of  the  15,000  marked  data, 
5,000 healthy population data  from 15,000 
data  were  eliminated,  and  the  remaining 
CHD patient data were labeled "1", and the 
other patients were labeled “−1”.
4)Dataset  partitioning was then performed in 
the second layer. Of the labeled 10,000 data, 
70% of the data were randomly sampled as a 
training set used for the training model, and 
the remaining 30% were used as a predictive 
set for model effect evaluation.
5)Model optimization was carried out for the 
specific data to adapt to different degrees, so 
the use of a grid search for parameter tuning 
was used for the prediction effect to achieve 
the optimum. 
6)Model  evaluation  included  evaluating  the 
performance  of  the  model,  the  diagnostic 
accuracy,  sensitivity,  specificity  and  preci-
sion  were  used  to  measure  the  diagnostic 
results. Using this model to diagnose the re-
sults  of  the predictive set,  the results  were 
compared with the known diagnostic results, 
and the accuracy, sensitivity and specificity 
of the model were obtained, and the specific 
meanings of these indexes are shown in Fig-
ure 1.
 
Figure  1.  The meanings  of  the  accuracy,  sensitivity  (recall), 
specificity and precision. The blue area means positive, the red 
area means negative, A is true positive, B is false negative, C is 
false  positive,  D  is  true  negative.  The  accuracy  is  (A+D)/
(A+B+C+D),  sensitivity  is  A/(A+B),  specificity  is  D/(C+D) 
and precision is A/(A+C)
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The results of the experimental evaluation were 
obtained by training tuning in Table-1 and Ta-
ble-2 for the three models. Three kinds of algo-
rithms, whether of the accuracy, sensitivity or 
specificity,  for  GBDT  were  better.  SVM  is 
more sensitive to data and it is difficult to find 
a suitable kernel function, and GBDT does not 
need to consider this problem. In the fitting ef-
fect, GBDT is a combination of a weak classi-
fier, not easy to occur with overfitting, and LR 
is easy to underfit. In the aspect of efficiency, 
SVM was  the  most  time-consuming and had 
the  lowest  efficiency  and  GBDT the  highest 
efficiency. To sum up, for all of the two layers 
we chose the GBDT algorithm. For the GBDT 
algorithm, if a logarithmic loss of function was 
similar to the logistic regression used, the loss 
of function is as follows.
where y∈{−1,+1}. Then, the negative gradient 
error is as follows.
For  the  resulting  decision  tree,  the  optimal 
residual fitting value for each leaf node is as 
follows.
The optimization of parameters is achieved by 
using a grid search, in which GBDT is optimal 
when  the  learning  rate  is  learning_rate=0.23 
and the maximum number of iterations is n_es-
timators=70.
GBDT in the classification, regression and oth-
er  machine  learning  tasks  had  very  good re-
sults. It has also been proven to be a very effi-
cient model in practice and is widely used.
VII. CALCULATION
The  two-layer  GBDT  algorithms,  which  were 
trained together, could be combined into three 
classification models for health, CHD and oth-
er  diseases.  In  fact,  we  could  also  use  the 
GBDT  three-classification  model  for  direct 
training and evaluation, but in view of the rea-
sons for the effective analysis of classification, 
the  machine  learning  black  box  had  to  be 
opened to a certain extent to obtain blood rou-
tine and related data items of the association 
law to further understand the blood routine de-
tection of the pathophysiology of data. At the 
same time, it is convenient to expand the clas-
sification  evaluation  to  other  diseases  in  the 
future, so we chose a two-layer GBDT model 
for the three classification, which is composed 
of two layers of GBDT algorithms, and the ex-
perimental  results  show  that  the  two-layer 
GBDT model  and  GBDT three  classification 
models are roughly the same in classification 
effect.  In  the  above  two-layer  GBDT model, 
the evaluation results are as follows in Table-3.
TABLE-1: RESULTS OF THE HEALTH AND THE 
DISEASES, COMPARISON OF PERFORMANCE 
INDEXES OF THREE DIFFERENT ALGORITHMS 
FOR THE FIRST LAYER MODEL
Algorithms Accuracy  Sensitivity Specificity
LR 84% 84% 83%
SVM 86% 87% 85%
GBDT 93% 93% 91%
TABLE-2: RESULTS OF CORONARY HEART 
DISEASE AND OTHER DISEASES,COMPARISON OF 
PERFORMANCE INDEXES OF THREE DIFFERENT 
ALGORITHMS FOR THE SECOND LAYER MODEL 
Algorithms Accuracy  Sensitivity Specificity
LR 85% 84% 84%
SVM 88% 87% 86%
GBDT 91% 93% 90%
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Calculation formula of CHD in three-classifi-
cation  model  of  two  classification  GBDT as 
follows.
Precision of CHD  =  Precision of first layer 
diseased people  *  Precision of second layer 
CHD
Recall of CHD  =  Recall of first layer diseased 
people  *  Recall of second layer CHD
According  to  these  calculation  formulas,  the 
Precision and Recall of CHD are shown in Ta-
ble-4.
VIII. RESULTS
To carry out  the risk assessment  of  coronary 
heart  disease at  a  low cost,  this  paper  estab-
lished a two-layer GBDT classification model 
by means of machine learning and classifica-
tion prediction of a large number of case data 
containing  blood  routine  data.  The  results  of 
the  classification  experiment  showed that  the 
model can identify approximately 86% of pa-
tients  at  high  risk  of  CHD.  This  model  pro-
vides a simple and low-cost approach to risk 
assessment of coronary heart disease.
Feature importance and correlation analysis
The GBDT algorithm is composed of multiple 
decision  trees,  and  each  tree's  construction 
process  is  performing  feature  selection, 
through the specified metrics, selecting a fea-
ture among the candidate features and the cor-
responding split value; the tree level of the fea-
ture is closer to the root node, the more divided 
the number of  times,  the more important  the 
features.
By using  the  Pearson  method to  analyze  the 
correlation of all of the features, the two-layer 
GBDT classification model was sorted by the 
feature importance,  among which three items 
with the highest contribution degree in the first 
layer  model  were RBC, HCT and LY%. The 
highest contribution to the second layer model 
in addition to age were PDW, RDW and MPV. 
We selected several features of higher contri-
bution to the healthy population and coronary 
heart  disease  population  from  two  contribu-
tions  ranking,  the  selected  features  including 
LY%, HCT, RBC, age, RDW, BASO% and LY 
for correlation analysis, as shown in Figure 2. 
The population of healthy people and coronary 
heart disease crowd dot matrix aggregation ef-
fect  is  obvious,  and among them, the blue is 
the  healthy  crowd,  red  is  the  coronary  heart 
disease  crowd,  and  obviously  the  healthy 
crowd's  aggregation  effect  is  better  than  the 
coronary heart disease crowd. This along with 
our result for the healthy population recall rate 
of 91% is higher than the coronary heart dis-
ease recall rate of 86.5%.
Furthermore, we present a visual representation 
of all features, blood routines and their associ-
ated data items, to further identify the complex 
relationships  between  these  features  and  the 
regularity of aggregation. We connected all of 
the  features  with  a  dashed line,  as  shown in 
Figure  3,  green  for  healthy  people,  red  for 
coronary heart disease and blue for other dis-
eases,  and  the  green  and  red  aggregation  is 
clearly  visible,  which confirms the classifica-
tion  results  of  our  model,  and  visualization 
presents its intrinsic reasons.
IX. DISCUSSION 
TABLE-3: CALCULATION RESULTS OF TWO-LAYER 
GBDT MODELS
Layers Classes Precision Recall
First 
Layer
Healthy people 87% 91%
Diseased people 96% 93%
Second 
Layer
Coronary heart 
disease (CHD)
90% 93%
Other diseases 92% 90%
TABLE-4: CALCULATION RESULTS OF CORONARY 
HEART DISEASE
Classes Precision Recall
Coronary heart 
disease(CHD)
86.4% 86.5%
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At present, the incidence of cardio-cerebrovas-
cular disease is increasing rapidly, and the high 
mortality, morbidity and relapse rates of coro-
nary heart disease lead to a heavy social and 
economic burden.  At  present,  China's  current 
cardiovascular disease patients number at least 
290  million,  including  myocardial  infarction 
patients  approximately  2.5  million,  and  each 
year, approximately 3.5 million people die of 
cardiovascular  disease,  the  highest  death  toll 
among all diseases.
Coronary  heart  disease  has  a  long  period  of 
onset, a slow progress, and no obvious symp-
toms until it becomes quite advanced. Once the 
onset of physical discomfort and other symp-
toms manifest, the disease has been present for 
many years, there is a life-threatening risk, and 
the cost of treatment is high. 
The current diagnosis of CHD is mainly based 
on coronary angiography, but it is obvious that 
the disease has to become quite serious before 
it is evident on coronary angiography. In view 
of the high incidence of coronary heart disease, 
its threat to health, and the treatments used for 
the disease, for early screening for CHD there 
are currently no good methods. Therefore, it is 
necessary  to  identify  a  simple  and  effective 
early screening method.
Our findings provide a scientifically effective, 
low-cost screening tool. The blood routine in-
dex can predict the risk of coronary heart dis-
ease so well  that we believe there must be a 
deep  pathophysiological  basis  behind  it.  In 
fact,  several  characteristics  of  coronary  heart 
disease changes in hemorheology, inflammato-
ry  response,  and  coagulation  function,  which 
can be reflected in the blood routine indicators. 
We selected  the  first  three  indexes  (coronary 
heart disease, healthy person and CHD, other 
disease Prediction Index) to review the litera-
ture and found that these indexes were reliable 
indexes  of  coronary  heart  disease  prediction 
and had their own associated pathophysiology.
RBC and coronary heart disease. The results 
showed that  RBC was significantly higher  in 
the  coronary  heart  disease  group  than  in  the 
control  group.  Coronary  heart  disease  causes 
the  organism  to  be  in  anoxic  condition,  and 
long-term hypoxia  stimulates  RBC and HGB 
compensatory generation to meet the increased 
needs of hypoxia; however, too many RBC and 
HGB promote  the  patient's  high  viscosity  of 
blood platelets  in  the arterial  wall  adhesions, 
red blood cell agglutination ability is enhanced 
and erythrocyte deformability is decreased, and 
thus  the  whole  blood  viscosity  is  increased. 
The  blood  flow  resistance  increases  in  the 
coronary artery and stenosis can easily result in 
thrombosis, causing myocardial infarction.
HCT and coronary heart disease. This study 
found that the HCT of coronary heart disease 
was higher than in the normal group although 
the specific mechanism is not very clear. It is 
generally believed that the whole blood viscos-
ity  is  an important  factor  to  determine blood 
flow, and HCT is  one of the determinants of 
whole  blood  viscosity.  HCT increases  in  red 
blood cell  aggregation,  resulting  in  increased 
viscosity.  Blood  viscosity  is  often  caused  by 
the  microcirculation  of  blood  flow  being 
slowed down and oxygen transport decreased, 
resulting in circulatory hypoxia, local hypoxia, 
and a high coagulation state. In addition, high 
levels of HCT are often associated with other 
risk  factors  such  as  BMI,  hypertension,  high 
cholesterol, impaired glucose tolerance, smok-
ing and so on, so the risk of coronary heart dis-
ease is higher in HCT patients.
Lymphocytes  and  coronary  heart  disease. 
The results  showed that  the ratio of  lympho-
cytes  in  patients  with  coronary  heart  disease 
decreased and the ratio of neutrophil/lympho-
cyte  was  higher  than  normal.  However,  the 
mechanism is not entirely clear. Some people 
think that a reduction in lymphocyte count may 
be due to physiological stress caused by corti-
cal hormone secretion and an immune response 
that is out of control.
PDW and coronary heart disease. The results 
showed that the PDW value of CHD patients 
was significantly higher than that in the healthy 
control group. Platelets are an important factor 
in initiating thrombosis, and a large volume of 
platelet function plays an important role in the 
development of coronary heart disease. PDW is 
a  parameter  that  reflects  the  heterogeneity  of 
platelet  size.  The  important  pathological 
changes in coronary heart disease are thrombo-
sis,  and  the  coagulation  activity  enhanced 
therein plays an important role, manifesting in 
platelet adhesion and gathering, and the release 
reaction  enhances  and  causes  thrombosis  be-
cause of the massive platelet consumption. The 
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marrow giant nucleus cell feedback multiplica-
tion is because the volume is too large, so the 
young platelets enter the peripheral blood, and 
the  massive  volume  of  platelet  activity  is 
strong. Released medium further participates in 
the  dynamic  evolution  of  the  atherosclerotic 
plaque  because  the  average  platelet  volume 
increases  so  that  the  size  of  platelets  is  in-
creased, and the PDW is also increased.
RDW and  coronary  heart  disease.  A large 
number  of  studies  have  confirmed  that  the 
RDW index  of  CHD  patients  is  higher  than 
among those in normal health. This index part-
ly reflects the severity of myocardial damage, 
and the higher the RDW level of patients, the 
worse the outcome. RDW and some inflamma-
tory markers such as n-terminal natriuretic pep-
tide  precursor  and  C-reactive  protein  have  a 
certain correlation. It is believed that RDW in-
flammation activity is increased and neuroen-
docrine  system  activation  is  closely  related. 
Another  mechanism may be  that,  because  of 
inflammatory cytokines, bone marrow red-line 
stem  cells  are  insensitive  to  erythropoietin 
stimulation,  preventing  their  resistance  to 
apoptosis  and  promoting  maturation.  Inflam-
matory cytokines inhibit the maturation of red 
blood  cells,  resulting  in  immature  red  blood 
cells  entering  the  circulation,  increasing  the 
size and heterogeneity of red blood cells, and 
raising the RDW.
MPV and coronary heart disease. MPV is the 
index used for evaluating platelet function and 
activity, and the size of MPV reflects the pro-
liferation and platelet formation of giant nucle-
us cells in the bone marrow and is closely re-
lated  to  platelet  life,  ultrastructure  and  their 
functional status in circulating blood, and a de-
crease  in  platelet  volume  indicates  that  their 
physical  substance,  activity  and  function  are 
decreased. An increase in MPV had a signifi-
cant positive correlation with a reduced bleed-
ing time, an increase in platelet A2 release, and 
the expression of the platelet membrane glyco-
protein Ⅰb and the Ⅱb/Ⅲa receptor.  Coronary 
heart disease patients have blood in a high co-
agulation  state,  and  thus  the  platelets  find  it 
easier to adhere to the accumulation and induce 
activation, forming a cycle of platelet relative 
reduction, and thus promoting a reaction of the 
bone marrow giant cells to produce large vol-
umes of platelets, so that the MPV increases.
We note that there are significant differences in 
the ranking of indicators for the two layers of 
health/disease and coronary heart disease/other 
diseases.  We  speculate  on  possible  causes: 
Many other diseases also have a certain effect 
on  routine  blood  tests,  so  that  some specific 
indicators may change in the direction of coro-
nary heart disease or the contrary, so that the 
contribution of a certain indicator may be more 
significant or not significant.
We also note that the scatter plot shown in Fig-
ure 2 in healthy people's indicators are relative-
ly concentrated, while the coronary heart dis-
ease  patients  are  relatively  dispersed  indica-
tors; there is a famous saying:
All happy families are all alike; every unhappy 
family is unhappy in its own way.
  --Leo Tolstoy, Anna Karenina           
Obviously, the healthy people's index similarity 
is relatively high, and the patient's condition is 
different. The index is relatively dispersed, but 
its overall or relative concentration has certain 
laws  to  follow.  This  is  the  reason  why  our 
model predicts better results.
X. CONCLUSIONS 
We developed a two-layer GBDT model based 
on routine blood test data to predict the risk of 
coronary heart disease, which can identify 86% 
of people with coronary heart disease. We built 
a dataset with 15,000 routine blood test data. 
On  this  dataset,  we  trained  several  machine 
learning  models  to  classify  health,  coronary 
heart disease and other diseases. As a result of 
the  classification  of  machine  learning,  we 
found  that  the  sensitivity  of  detecting  the 
health data was approximately 93% in all data, 
and the sensitivity of detecting CHD was 93% 
in  the  diseases  data,  that  included  coronary 
heart disease. On this basis, we further visual-
ized the correlation between routine blood tests 
and related data items, and there was an obvi-
ous  regularity  for  health  and  coronary  heart 
disease in all of the data presentations, which 
can be used for clinical reference. Finally, we 
briefly analyzed the pathophysiology of these 
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results from the perspective of pathophysiolo-
gy.
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Figure 2. Correlation between LY%, HCT, RBC, age, RDW, BASO% and LY. The population of healthy people 
and coronary heart disease crowd dot matrix aggregation effect is obvious. Among them the blue is the healthy 
crowd, red is the coronary heart disease crowd, and obviously the healthy crowd's aggregation effect is better 
than the coronary heart disease crowd.
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Figure 3. Visual analysis of features correlation: green for healthy people, red for 
coronary heart disease and blue for other diseases. Green and red aggregation is 
clearly visible, which confirms the classification results of our model, the 
visualization presents its intrinsic reasons.
